Non-homologous end joining (NHEJ) is a major repair pathway for DNA double-strand breaks (DSBs) generated by ionizing radiation (IR) and anti-cancer drugs. Therefore, inhibiting the activity of proteins involved in this pathway is a promising way of sensitizing cancer cells to both radiotherapy and chemotherapy. In this study, we developed an assay for evaluating NHEJ activity against DSBs in chromosomal DNA in human cells to identify the chromatin modification/remodeling proteins involved in NHEJ. We showed that ablating the activity of the homologous histone acetyltransferases, CBP and p300, using inhibitors or small interfering RNAs-suppressed NHEJ. Ablation of CBP or p300 impaired IR-induced DSB repair and sensitized lung cancer cells to IR and the anti-cancer drug, etoposide, which induces DSBs that are repaired by NHEJ. The CBP/p300 proteins were recruited to sites of DSBs and their ablation suppressed acetylation of lysine 18 within histone H3, and lysines 5, 8, 12, and 16 within histone H4, at the DSB sites. This then suppressed the recruitment of KU70 and KU80, both key proteins for NHEJ, to the DSB sites. Ablation of CBP/p300 also impaired the recruitment of BRM, a catalytic subunit of the SWI/SNF complex involved in chromatin remodeling at DSB sites. These results indicate that CBP and p300 function as histone H3 and H4 acetyltransferases at DSB sites in NHEJ and facilitate chromatin relaxation. Therefore, inhibition CBP and p300 activity may sensitize cancer cells to radiotherapy and chemotherapy.
Introduction
Non-homologous end joining (NHEJ) is a repair pathway for DNA double-strand breaks (DSBs) that joins two broken DNA ends without the need for sequence homology. DSBs caused by ionizing radiation (IR) are preferentially repaired through NHEJ (Burma et al., 2006; Lieber, 2008) . Therefore, suppression of NHEJ is a promising therapy that may sensitize cancer cells to IR (Helleday et al., 2008) . In addition, DSBs caused by anticancer drugs such as the topoisomerase II inhibitor, etoposide, may also be repaired through NHEJ (Adachi et al., 2003) ; therefore, suppression of NHEJ is also a promising approach to sensitizing cancer cells to these drugs (Zhao et al., 2006; Helleday et al., 2008) . In vitro studies have elucidated the molecular processes underlying NHEJ of DNA ends, in which KU70/80 and DNA-dependent protein kinases (DNA-PKcs) function as core proteins (Burma et al., 2006; Lieber, 2008) . Chemicals that inhibit DNA-PKcs activity and sensitize cancer cells to IR and/or etoposide are awaiting evaluation for clinical application (Helleday et al., 2008) . Thus, identification of novel proteins involved in NHEJ will help to develop methods for sensitizing cancer cells to both radiotherapy and chemotherapy.
Chromosomal DNA and histones form a highly condensed structure known as chromatin. The accessibility of proteins to chromosomal DNA in vivo is required for a variety of intracellular processes, including DSB repair, and is regulated by two general chromatin remodeling mechanisms, histone modification and alteration of the nucleosomal position (Osley and Shen, 2006) . Acetylation of histones located at DSB sites by histone acetyltransferases (HATs) is a critical chromatin modification required for DSB repair. In particular, the N-terminal lysine residues of histones H3 and H4 are acetylated during DSBs (Bird et al., 2002; Tamburini and Tyler, 2005) . Consistent with this, NuA4-Tip60 HAT acetylates histone H4 at DSB sites and facilitates DSB repair (Bird et al., 2002; Murr et al., 2006) . In addition to HATs, the SWI2/SNF2 superfamily (INO80, SWR1, SWI/SNF and RSC) chromatin remodeling complexes are recruited to DSB sites and facilitate alterations in the nucleosomal position. Furthermore, the INO80, SWR1 and RSC complexes are required for the recruitment of KU70/80 to DSB sites (Shim et al., 2005; van Attikum et al., 2007) . It is also suggested that the SWI/SNF complex is recruited to DSB sites, where it interacts with acetylated histone proteins and g-H2AX, a phosphorylated H2AX protein generated upon DSBs (Lee et al., 2010) . Taken together, these studies suggest that histone acetylation facilitates chromatin remodeling and that the resulting 'relaxed' chromatin enables the recruitment of DNA repair proteins to DSB sites. However, the HATs and chromatin remodeling complexes involved in NHEJ have not been fully understood. In addition, the effect of inhibiting these proteins on the radiosensitivity and chemosensitivity of cancer cells remains largely unknown.
In this study, we developed an assay system to evaluate NHEJ activity after DSBs in chromosomal DNA in human cells. Using this system, we found that two HAT inhibitors, anacardic acid and curcumin, both known to radio-sensitize cancer cells (Khafif et al., 2005; Sun et al., 2006; Javvadi et al., 2008) , suppress NHEJ of DSBs. The CBP and p300 proteins are homologous HATs, known to function as transcription co-activators, and their enzymatic activity is inhibited by anacardic acid and curcumin (Karamouzis et al., 2007) . We showed that CBP and p300 function as histone H3 and H4 acetyltransferases at DSB sites during NHEJ, and facilitate the recruitment of KU70/80 proteins in cooperation with the SWI/SNF chromatin remodeling complex. Ablation of CBP and p300 caused radiosensitization of lung cancer cells and sensitized the cells to etoposide. These results indicate that the CBP and p300 proteins are involved in NHEJ in vivo and act as histone H3 and H4 acetyltransferases, facilitating chromatin relaxation. Inhibition of CBP and p300 activity may, therefore, be a way to sensitize cancer cells to radiotherapy and chemotherapy.
Results
Development of an NHEJ assay system for DSBs in chromosomal DNA The assay system for evaluating NHEJ activity against DSBs in chromosomal DNA in living human cells is presented in Figure 1a . The IRES-TK-EGFP plasmid, which contains two recognition sites for I-SceI endonuclease (Jasin, 1996) in the reverse direction, was integrated into the chromosomal DNA of human cells as a substrate for DSBs and subsequent NHEJ repair. As there is no I-SceI site in the human genome, the I-SceI protein transiently expressed by transfection of the I-SceI expression plasmid specifically cleaves two I-SceI sites in the substrate and produces DSBs with incompatible ends. This results in DSBs in chromosomal DNA in vivo. NHEJ of the two broken DNA strands results in the deletion of the herpes simplex virusthymidine kinase open reading frame and leads to the production of a transcript that enables translation of enhanced green fluorescent protein (EGFP) instead of the herpes simplex virus-thymidine kinase protein. Therefore, the efficiency of NHEJ can be assessed by monitoring EGFP production. In addition, the DSBs produced by I-SceI and NHEJ of the two broken DNA strands can be monitored by quantitative PCR (As shown in Figure 1a , 'the proportion of uncut DNA' is used to assess the efficiency of DSB generation by I-SceI and 'the proportion of joined DNA' is used to assess the ligation efficiency of the DNA ends).
We isolated two individual H1299 human lung cancer cell clones, H1299dA3-1 #1 and #2, that stably carried the IRES-TK-EGFP DNA within their genome (Supplementary Figure S1A and S1B). Fluorescenceactivated cell sorting analysis showed that the proportion of cells expressing EGFP increased 24-72 h after transfection of the I-SceI expression plasmid in both clones ( Figure 1b and Supplementary Figure S1C ). Quantitative PCR analysis revealed that the proportion of joined DNA increased 12-48 h post transfection, whereas that of uncut DNA decreased during the 24 h post transfection (Figures 1c and d) . Therefore, DSBs were introduced by I-SceI, and the subsequent joining of the two broken DNA ends occurred in both the H1299dA3-1 #1 and #2 clones in vivo. Nucleotide sequencing of the joined DNA revealed that the ligation required no (or very little) sequence homology between the DNA ends (Supplementary Figure S1D) , indicating that the DNA ends were joined via NHEJ.
We next examined the effect of inhibiting DNA-PKcs activity on the joining of DNA ends using this assay system. In both the H1299dA3-1 #1 and #2 clones, the proportion of both EGFP-positive cells and joined DNA decreased after treatment with the DNA-PKcs inhibitor, NU7026, at a concentration wherein phosphorylation of the serine 2056 residue of the DNA-PKcs protein (activated by autophosphorylation) by IR is suppressed. This occurred without any increase in the proportion of uncut DNA (Figures 1e-g and Supplementary Figure S1E ). The proportion of EGFP-positive cells was also decreased by small interfering RNA (si)RNA-mediated ablation of DNA-PKcs (Figure 1h ). These results confirmed that the two DNA ends produced by I-SceI digestion were joined through NHEJ, and indicated that a reduction in NHEJ activity by treatment with inhibitors and siRNAs directed against other proteins involved in NHEJ should also be detectable by this assay.
Suppression of NHEJ in vivo by ablation of CBP or p300
To identify the HATs involved in NHEJ, we first examined whether the NHEJ in this assay could be suppressed by HAT inhibitors. The HAT inhibitors examined were anacardic acid (from cashew nuts), which inhibits PCAF, p300 and TIP60 (Balasubramanyam et al., 2003 (Balasubramanyam et al., , 2004 Sun et al., 2006) , and curcumin (from turmeric), which inhibits CBP and p300 (Balasubramanyam et al., 2004) . These HAT inhibitors are known to radio-sensitize cancer cells (Khafif et al., 2005; Sun et al., 2006; Javvadi et al., 2008) . As with NU7026, treatment with anacardic acid and curcumin sensitized lung cancer cells to IR (Figure 2a ) and led to a reduction in the proportion of EGFP-positive cells in the NHEJ assay ( Figure 2b, Supplementary Figure S2 ). Quantitative PCR analysis revealed that the proportion of joined DNA was reduced by both anacardic acid and curcumin, without any significant changes in the proportion of uncut DNA (Figures 2c and d) . These results indicated that HAT inhibitors were able to suppress NHEJ, and that this activity contributes to the radiosensitization of cancer cells.
We next examined the effect of siRNA-mediated ablation of PCAF, TIP60, CBP and p300 on NHEJ Role of CBP/p300 in non-homologous end joining H Ogiwara et al ( Figure 2e ). Ablation of TIP60, a HAT thought to be involved in NHEJ (Robert et al., 2006; Sun et al., 2006) , led to a reduction in the proportion of EGFP-positive cells. Interestingly, ablation of CBP and p300 also caused a reduction in the proportion of EGFP-positive cells, whereas ablation of PCAF did not (Figure 2e ). Similar reductions in the proportion of EGFP-positive cells after ablation of CBP and p300 were confirmed using other siRNAs (Figure 2f ). The proportion of joined DNA was reduced after ablation of CBP and p300, without any significant change in the proportion of uncut DNA (Figures 2g and h ). This strongly suggests the involvement of CBP, p300 and TIP60, but not PCAF, in NHEJ.
To further confirm these results, we examined the effect of ablating CBP and p300 on the repair of IR-induced DSBs using the neutral comet assay, which specifically detects DSBs. The repair of IR-induced Role of CBP/p300 in non-homologous end joining H Ogiwara et al
DSBs was suppressed in cells in which CBP and p300 were ablated ( Figure 3a ). This ablation also sensitized H1299 lung cancer cells to IR (Figures 3b and c) . Consistently, ablation of CBP or p300 also sensitized the cells to etoposide, which causes DSBs that are preferentially repaired through NHEJ (Adachi et al., 2003) ( Figure 3d ). These results indicated that the CBP and p300 proteins were involved in the NHEJ of DSBs induced by IR and anti-cancer drugs, as well as those induced by the I-SceI restriction enzyme.
Recruitment of CBP and p300 to DSB sites Both CBP and p300 function as HATs during transcriptional regulation (Karamouzis et al., 2007) . Ablation of CBP/p300 did not significantly affect the expression levels of NHEJ core proteins (Supplementary Figure S3) , indicating that the suppression of NHEJ through ablation of CBP or p300 was caused by mechanisms other than the downregulation of proteins engaged in NHEJ. Therefore, we next examined whether the CBP and p300 proteins were recruited to sites of DSBs in chromosomal DNA in the same manner as other proteins involved in NHEJ (Mari et al., 2006) . Recruitment of CBP and p300 to DSB sites generated by I-SceI digestion was examined using chromatin immunoprecipitation (ChIP) analysis of DSBs in H1299dA3-1 #1 cells (Figure 4a ). Quantitative PCR analysis of the 0.3, 1.2 and 2.5 kb regions downstream of the second I-SceI site in the pIRES-TK-EGFP plasmid sequence immunoprecipitated with control immunoglobulin G or anti-gH2AX antibodies showed an enrichment of gH2AX, a phosphorylated form of H2AX generated by DSBs. This was observed not only in the 0.3 kb region, but also in the 1.2 and 2.5 kb regions, consistent with a previous finding that gH2AX lies B10 kb from the DNA ends (Bonner et al., 2008) . However, enrichment of CBP and p300 proteins was only observed in the 0.3 kb region, and not in the 1.2 and 2.5 kb regions, after I-SceI digestion. The CBP and p300 proteins in laser micro-irradiated regions were co-localized with gH2AX and 53BP1, both markers for DSB sites (Figure 4b ). This was confirmed using a different set of antibodies (Figure 4c ). In addition, exogenously expressed mouse Cbp protein tagged with yellow fluorescent protein (YFP-Cbp) also accumulated in laser micro-irradiated regions (Figure 4d ). These results strongly indicated that CBP and p300 were recruited to the sites of DSBs in vivo.
Impairment of DSB-induced histone H3/H4 acetylation and KU recruitment by ablation of CBP or p300 It is thought that CBP and p300 have HAT activity against histones H3 and H4, as p300 acetylates lysines 14 and 18 of histone H3, and lysines 5 and 8 of histone H4, in vitro (Schiltz et al., 1999; Park et al., 2003; Kouzarides, 2007) . In addition, lysine 18 within histone H3 is acetylated by CBP and p300 in vivo (Horwitz et al., 2008) . Acetylation of histone H3 and H4 at DSB sites has an important role in DSB repair (Bird et al., 2002; Tamburini and Tyler, 2005; Park et al., 2006; Robert et al., 2006; Sun et al., 2006; Pandita and Richardson, 2009 ). In particular, acetylation of lysines 5, 8, 12 and Role of CBP/p300 in non-homologous end joining H Ogiwara et al 16 within histone H4 (H4 K5/K8/K12/K16) is critical for NHEJ (Bird et al., 2002) , whereas lysine 18 within histone H3 (H3 K18) is also acetylated in DSBs (Tamburini and Tyler, 2005) . However, whether CBP and p300 function as histone H3 and H4 HATs during DSB repair is unknown. Therefore, we examined the involvement of CBP and p300 in the acetylation of histones H3 and H4 at DSB sites by ChIP analysis using anti-acetylated histone antibodies. DSBs induced by I-SceI digestion caused acetylation of H4 K5/K8/K12/ K16 and H3 K18 within the 0.3 kb region (designated as the 300D locus) from the I-SceI site (Figures 5a and b ) without significantly affecting their acetylation within the GAPDH region located on a chromosome different from that containing the I-SceI locus (Supplementary Figure S4A and S4B). Acetylation at the 300D locus induced by I-SceI digestion was suppressed by ablation of CBP or p300 (Figures 5a and b) . However, the quantity of histone H3 at the 300D locus was not significantly affected by I-SceI digestion and/or by CBP Role of CBP/p300 in non-homologous end joining H Ogiwara et al or p300 ablation (Figure 5c ). Acetylation of lysine 56 within histone H3 at the 300D locus was not significantly suppressed by ablation of CBP or p300 ablation (Supplementary Figure S4C) . We also examined acetylation of lysines 9 and 14 within histone H3 (H3 K9K14) but could not detect any I-SceI-induced acetylation (data not shown), although the DSB-induced acetylation of H3 K9K14 was observed in another I-SceIinduced DSB system . These results indicated that the CBP/p300 proteins specifically acetylated H4 K5/K8/K12/K16 and H3 K18 at DSB sites. Recruitment of KU70/KU80 proteins is a critical step in the ligation of DNA ends through NHEJ (Burma et al., 2006; Lieber, 2008) . Therefore, we examined the effect of ablating CBP or p300 on the recruitment of KU80 and KU70 proteins using ChIP analysis, and found that it was suppressed after ablation of CBP or p300 (Figure 5d and Supplementary Figure S4D) . Furthermore, ablation of CBP or p300 also suppressed the accumulation of exogenously expressed human KU70 tagged with green fluorescent protein (GFP-KU70) in laser micro-irradiated sites (Figures 5e and f) . This suggested that histone acetylation by CBP and p300 at DSB sites facilitates the recruitment of KU70/80.
Impairment of SWI/SNF chromatin remodeling protein recruitment to DSB sites by CBP or p300 ablation We next investigated how acetylation of histones H3 and H4 by CBP/p300 contributes to NHEJ. The accessibility of proteins to DNA in vivo is regulated by cooperation between histone modification and alterations in the nucleosomal position (Osley and Shen, 2006) . In fact, it was recently suggested that histone acetylation is required for the recruitment of the SWI/ SNF complex to DSB sites (Lee et al., 2010) . SWI/SNF is a chromatin remodeling complex that enhances DSB repair (Park et al., 2006) . Thus, we examined the effects of BRM ablation (one of the two catalytic subunits of the SWI/SNF complex) on NHEJ using H1299 dA3-1 #1 cells. As H1299 cells lack a functional BRG1 gene (Medina et al., 2008) , which encodes the other catalytic subunit, it was predicted that the SWI/SNF complex would be inactivated by ablation of BRM in our assay system. BRM ablation caused a reduction in the proportion of both EGFP-positive cells and joined DNA, without any significant change in the proportion of uncut DNA (Figures 6a and c) . Furthermore, BRM ablation also suppressed the accumulation of exogenously expressed GFP-KU70 protein at laser micro-irradiated sites (Figures 6d and e) . These results suggested the involvement of BRM in NHEJ. Importantly, ablation of the CBP or p300 proteins suppressed the accumulation of exogenously expressed GFP-tagged human BRM protein (GFP-BRM) at laser microirradiated sites (Figures 6f and g ). ChIP analysis also indicated that the recruitment of BRM to DSB sites generated by I-SceI digestion was also suppressed by CBP or p300 ablation (Supplementary Figure 5) . These results suggest that histone acetylation at DSB sites by CBP and p300 proteins facilitates the recruitment of the SWI/SNF chromatin remodeling complex, and the Role of CBP/p300 in non-homologous end joining H Ogiwara et al resulting 'relaxed' chromatin enables the accumulation of the core NHEJ proteins.
Discussion
We have developed an assay system that allows the evaluation of ligation activity in chromosomal DNA in vivo. Suppression of DNA joining by inhibitors or siRNAs targeting DNA-PKcs, along with the structure of the breakpoint junctions within DSBs generated by I-SceI endonuclease, indicate that ligation is mediated by NHEJ in this system. However, the treatment of cells with the HAT inhibitors, anacardic acid and curcumin, also suppressed NHEJ in this system. Acetylation of the N-terminal lysines 5, 8, 12 and 16 within histone H4 (H4 K5/K8/K12/K16) is critical for NHEJ (Bird et al., 2002) . TIP60 functions as an acetyltransferase for the N-terminal residues of histone H4 at DSB sites in both yeast and mammalian cells (Downs et al., 2004 ; Role of CBP/p300 in non-homologous end joining H Ogiwara et al Murr et al., 2006) . However, it was not known whether TIP60 is required for NHEJ in vivo. In this study, we showed that siRNA-mediated ablation of TIP60, a target of anacardic acid (Sun et al., 2006) , suppressed NHEJ. The results also indicated that NHEJ is accomplished through chromatin modification by HATs (Valerie and Povirk, 2003; Downs, 2007) , and that this assay system can be used to examine the molecular mechanisms involved in NHEJ in vivo, including that of HATs and other chromatin remodeling proteins. ChIP analysis showed that DSB-induced acetylation of lysines 5, 8, 12 and 16 within histone H4 occurs in both yeast and mammalian cells (Downs et al., 2004; Tamburini and Tyler, 2005; Murr et al., 2006) . This was confirmed by our system. DNA damage-induced acetylation of N-terminal lysines 9, 14, 18, 23 and 56 within histone H3 in mammalian cells was observed by immunoblot analysis (Das et al., 2009; Tjeertes et al., 2009; Yuan et al., 2009; Lee et al., 2010; Miller et al., 2010) . However, the results were controversial. Furthermore, these studies only examined global acetylation, not specific acetylation at DSB sites. The significance of H3 acetylation at DSB sites was demonstrated by showing acetylation of H3 K9/K14 and deacetylation of H3 K56 at these sites by ChIP analysis Miller et al., 2010) . In our study, acetylation of histone H3 upon DSBs was also observed using ChIP analysis, validating the significance of histone H3 acetylation at DSB sites. Interestingly, H3 K18, rather than H3 K9/K14 or H3 K56, was acetylated at the DSB sites in our study. The inconsistent result regarding H3 K9/K14 might be due to differences in the assay systems used; the present assay reproduced repair by NHEJ, whereas that of Murr et al. reproduced repair by homologous recombination . Ablation of CBP, p300 and TIP60 suppressed NHEJ, whereas ablation of PCAF did not. These results indicate that multiple, but not all, HATs are involved in the facilitation of NHEJ via acetylation of histones at DSB sites. Acetylation of H3 K18 and H4 K5/K8/K12/ K16, but not H3 K56, at DSB sites was suppressed by the ablation of CBP or p300. Importantly, CBP and p300 accumulated at the DSB sites. Therefore, CBP and p300 acetylate these N-terminal histone residues at the DSB sites to facilitate NHEJ. Another HAT, GCN5, is also thought to be involved in the acetylation of histone H3 at DSB sites, although its involvement in NHEJ has not been investigated (Park et al., 2006) . Thus, at least four HATs (TIP60, CBP, p300 and GCN5) are likely to have redundant roles in histone acetylation at DSB sites in human cells. HATs, including CBP and p300, also acetylate non-histone proteins (Karamouzis et al., 2007) . Further study is needed to elucidate the NHEJ mechanisms facilitated by these HATs.
NHEJ proceeds in a stepwise manner employing multiple proteins. First, the broken DNA ends are recognized by KU70/80. DNA-PKcs then forms a complex with the KU70/80 proteins that brings the two DNA ends together. Finally, the two DNA ends are joined by the LIGIV/XRCC4 complex (Burma et al., 2006; Lieber, 2008) . As the structure of chromatin forms a barrier to DNA-protein interactions, it is likely that NHEJ requires chromatin remodeling. This consists of histone modification by HATs and alteration of the nucleosome positions within the chromatin by chromatin remodeling complexes. Importantly, ablation of CBP or p300 HATs impaired the recruitment of the KU70/80 proteins to DSB sites. This result complements a recent result showing that inhibition of histone deacetylases enhances the association of NHEJ factors with DSB sites (Miller et al., 2010) . Taken together, these results strengthen the importance of histone acetylation at DSB sites for the recruitment of NHEJ factors. Members of the SWI2/SNF2 superfamily (INO80, SWR1, SWI/SNF and RSC) of chromatin remodeling complexes were found at single DSBs in budding yeast (van Attikum et al., 2004; Chai et al., 2005; Shim et al., 2005) . Therefore, these complexes were postulated to have a role in DSB repair by altering the nucleosome positions at the DSB sites. In this study, ablation of both the catalytic subunits of the SWI/SNF complex (BRM (by RNAi) and BRG1 (inactivated by mutation in H1299 cells used for analysis)) impaired the recruitment of KU70 to the DSB sites in human cells. Significantly, accumulation of BRM at DSB sites was also impaired by the ablation of CBP or p300. This indicated that histone acetylation by CBP or p300 at DSB sites facilitates the recruitment of the SWI/SNF complex. This result is consistent with a report that nucleosomes containing gH2AX, and histone H3 with mutations in the acetylation sites, lack the ability to interact with the SWI/SNF complex (Lee et al., 2010) . In summary, the present results strongly indicate that the CBP and p300 proteins function as HATs for histone H3 and H4 at DSB sites and facilitate the recruitment of the SWI/SNF chromatin remodeling complex. The resultant 'relaxed' chromatin allows NHEJ by facilitating the recruitment of core NHEJ proteins. These results are supported by the fact that the INO80, SWR1 and RSC complexes are required for the recruitment of KU70/80 proteins to DSB sites in budding yeast (Shim et al., 2005; van Attikum et al., 2007) . However, both CBP and p300 have a role during transcription, either as a physical bridge for diverse proteins, or as a scaffold for the formation of multicomponent complexes. In addition, acetylation of nonhistone proteins, such as p53, by CBP and p300 enhances their DNA-binding activity and regulates protein-DNA recognition (Karamouzis et al., 2007) . Thus, the functions of CBP and p300, other than that of HATs, might also help the recruitment of KU70/80 proteins. It was reported that CBP associates with and acetylates KU70 in vitro (Cohen et al., 2004) . However, we could not detect any interaction between CBP or p300 and KU70/80 in the cell nucleus (data not shown). Thus, CBP/p300 might not have a role in NHEJ as an acetyltransferase for KU70 itself, but might function as a scaffold and/or acetyltransferase for non-histone proteins to recruit KU70/80.
Enhanced DSB repair activity within cancer cells, which allows them to evade IR and anti-cancer druginduced cell death, is a problematic issue in cancer therapy. Thus, the suppression of NHEJ activity is a promising therapeutic method for sensitizing cancer cells to radiotherapy and chemotherapy (Helleday et al., 2008) . In this study, siRNA-mediated ablation of CBP/ p300 increased the radio-sensitivity of lung cancer cells. Therefore, inhibition of CBP/p300 activity using specific inhibitors or siRNAs would be a novel way of sensitizing cancer cells to radiotherapy. Ablation of CBP/p300 also increased the sensitivity of lung cancer cells to the anti-cancer drug, etoposide, which induces DSBs that are repaired by NHEJ (Adachi et al., 2003) . Therefore, inhibition of CBP/p300 would also be an effective way to sensitize cancer cells to chemotherapy.
Materials and methods

Construction of plasmids
The pIRES-TK-EGFP plasmid used for the NHEJ assay (Supplementary Figure S1A) was constructed by inserting a DNA fragment containing herpes simplex virus-thymidine kinase open reading frame from the pAD-TK plasmid and a DNA fragment containing the EGFP open reading frame from the pmaxGFP plasmid (Amaxa, Cologne, Germany) into the pIRESpuro3 plasmid (BD Bioscience Clontech, Mountain View, CA, USA). The pCBASce, an I-SceI expression plasmid, was obtained from Dr Maria Jasin (Johnson et al., 1999) . Plasmids expressing human KU70 and BRM complementary DNA were constructed by subcloning complementary DNA derived from HeLa cell RNA into a modified EGFP-C1 plasmid (Hong et al., 2008) , which contains multiple cloning sites for the introduction of complementary DNAs with inframe XhoI NotI sites at the start and stop codons, respectively. The integrity of the constructs was verified by sequencing. Plasmid DNAs were propagated in, and purified from, DH10B E.coli cells (Invitrogen, Carlsbad, CA, USA).
Materials
H1299 and H1299dA3-1 human lung cancer cells were cultured in RPMI 1640 supplemented with 10% fetal bovine serum at 37 1C with 5% CO 2 . NU7026 and curcumin were purchased from Sigma (St Louis, MO, USA), and anacardic acid was purchased from Merck (Hamburg, Germany). The following siRNA duplexes were purchased from Dharmacon (Yokohama, Japan): siCTR (L-001810-10), siDNAPKcs (L-005030-00), siKU70 (L-005084-00), siKU80 (L-010491-00), siTIP60 (L-006301-00), siCBP (L-003477), siCBP#1 (J-003477-06), siCBP#2 (J-003477-09), sip300 (L-003486-00), sip300#1 (J-03489-11), sip300#2 (J-03489-12), siPCAF (L-005055-00) and siBRM (L-017253-00). Antibodies were purchased from Sigma (a-tubulin, T6199; b-actin, A5441), Abcam (Cambridge, MA, USA) (DNA-PKcs, pS2056 and ab18192; PCAF, ab12188; XRCC4, ab12069; 53BP1, ab36823), Calbiochem (San Diego, CA, USA) (DNA-PKcs, NA57), Santa Cruz Biotechnology (San Diego, CA, USA) (CBP, sc369 and sc7300; p300, sc585 and sc48343; KU70, sc9033; KU80, sc9034; LIGIV, sc11750), Becton Dickinson (Franklin Lakes, NJ, USA) (BRM, 610390), Active Motif (Carlsbad, CA, USA) (Histone H3, 39164), Epitomics (Burlingame, CA, USA) (acetylated H3 (K56), 2134-1) and Millipore (Billerica, MA, USA) (gH2AX, TIP60, acetylated H4 (K5/8/12/16), acetylated H3 (K18), .
NHEJ assay
The pIRES-TK-EGFP DNA, linearized by FspI restriction enzyme digestion, was transfected into H1299 cells using the Lipofectamine 2000 reagent (Invitrogen), and two clones, H1299dA3-1 #1 and #2, resistant to puromycin (2.5 mg/ml) were obtained. Retention of pIRES-TK-EGFP DNA was confirmed by genomic PCR. Integration of the pIRES-TK-EGFP DNA into chromosomal DNA was confirmed by fluorescence in situ hybridization analysis (Yoshida et al., 2001) . A 2.7-kb fragment covering herpes simplex virusthymidine kinase and GFP from the pIRES-TK-EGFP plasmid was used as a probe, together with a whole chromosome painting probe for chromosome 15 (CAMBIO, Cambridge, UK). IRES-TK-EGFP DNA was detected in a marker chromosome in #1 cells in 41 (91%) out of 45 metaphases examined (Supplementary Figure S1B) . IRES-TK-EGFP DNA was integrated in one to three chromosomes in #2 cells in 47 (94%) out of 50 metaphases examined.
The pCBASce plasmid DNA (0.8 mg) was introduced into 7.5 Â 10 4 of H1299dA3-1 #1 and #2 cells per well in a 24-well plate by transfection with Lipofectamine 2000 reagent. For fluorescence-activated cell sorting analysis, cells were harvested by trypsinization, washed with phosphate-buffered saline and applied to a FACSCalibur (Becton Dickinson). For quantitative PCR analysis, genomic DNA was purified from cells using Illustra Tissue and Cells GenomicPrep Mini Spin kits (GE Healthcare, Tokyo, Japan), and 20 ng of DNA was subjected to quantitative PCR to quantify the uncut and joined DNAs using an ABI 7900HT fast real-time PCR system analyzer (Applied Biosystems, Foster City, CA, USA). PCR was performed for 45 cycles consisting of denaturation at 95 1C for 30 s, and annealing and extension at 60 1C for 60 s using a QuantiTect Probe PCR kit (Qiagen, Valencia, CA, USA). GAPDH DNA was co-amplified and quantified as an internal control. The primers and probes used for quantitative PCR are listed in Supplementary Table S1 . The proportion of uncut DNA (reflecting the efficiency of I-SceI digestion) was reproducibly observed to be 0.5-0.6, regardless of the siRNA or inhibitor treatments described below. To examine the effects of inhibitors on DNA joining, an inhibitor or dimethyl sulfoxide (Sigma) alone (used as a solvent for the inhibitors) was added at the time of pCBASce plasmid transfection. To examine the effects of siRNAs on DNA joining, cells were subjected to the NHEJ assay and immunoblot analysis 48 h after siRNA transfection. The siRNAs were transfected at a concentration of 50 nM using Lipofectamine RNA MAX (Invitrogen). The inhibitor concentrations were as follows: NU7026: 50 mM; anacardic acid: 50 mM; curcumin: 20 mM.
Clonogenic assay H1299 cells were pre-treated with dimethyl sulfoxide or each HAT inhibitor (anacardic acid: 25 or 50 mM; curcumin: 10 or 20 mM) for 1 h, or pre-transfected with siRNA for 48 h, and subjected to (or not) irradiation at 2.5, 5 or 10 Gy. The cells were plated onto 60-mm dishes and surviving colonies were counted after 10 days. The number of colonies derived from treated cells is expressed as a ratio against that of untreated cells (control).
Immunoblot analysis
Cells were harvested, washed with phosphate-buffered saline and lysed in 100 ml NETN300 buffer (20 mM Tris-HCl, pH 7.5, 300 mM NaCl, 0.5% NP-40, 1 mM EDTA) containing 1 mM phenylmethylsulfonyl fluoride, 10 mM sodium butyrate, a proteinase inhibitor cocktail and a phosphatase inhibitor cocktail (Roche Diagnostics, Indianapolis, IN, USA). After 30 min of incubation on ice, the samples were centrifuged for 10 min at 14 000 r.p.m. at 4 1C. Supernatants were mixed with SDS sample buffer, boiled and subjected to SDS-polyacryl-amide gel electrophoresis, followed by blotting onto a polyvinylidene difluoride membrane. The membranes were blocked overnight with Tris-buffered saline containing 0.1% Tween 20 and 0.5% bovine serum albumin, and probed with primary antibodies. After washing with Tris-buffered saline containing 0.1% Tween 20, the membranes were incubated with horseradish peroxidase-conjugated anti-mouse or antirabbit secondary antibodies and treated with an enhanced chemiluminescence reagent (GE Healthcare).
ChIP assay
H1299dA3-1 cells (2 Â 10 6 ) were plated in 100-mm dishes and transfected with or without 16 mg of the pCBASce plasmid using Lipofectamine RNAMAX (Invitrogen). At 0, 12 or 18 h after transfection, cells were treated with 1% formaldehyde for 10 min at room temperature to cross-link proteins to DNA, followed by addition of glycine (0.125 M) to stop the crosslinking. Cells were collected with a cell scraper and washed in ice-cold phosphate-buffered saline. The ChIP assay was performed using a ChIP IT Express Enzymatic kit (Active Motif) according to the manufacturer's protocol. Briefly, resuspended cells were subjected to DNA shearing for 10 min at 37 1C, followed by the addition of EDTA to stop the reaction. A portion of the samples was set aside for input control, whereas the remaining portion was subjected to immunoprecipitation performed at 4 1C overnight. The cross-links were reversed in a reverse cross-linking buffer for 15 min at 95 1C, and the samples were de-proteinized for 1 h at 37 1C using proteinase K. Aliquots were subjected to quantitative PCR using the primer/probe set shown in Supplementary Table S1 and an ABI 7900HT fast real-time PCR system analyzer (Applied Biosystems). PCR was performed for 45 cycles consisting of denaturation at 95 1C for 30 s, and annealing and extension at 60 1C for 60 s using a QuantiTect Probe PCR kit (Qiagen). The proportion of DNAs from the test loci crosslinked to proteins was calculated based on the quantity of DNA in the input control samples at each time point. The relative enrichment of a protein at the test sites was expressed as the amount of immunoprecipitated DNA divided by the amount of input DNA, and plotted as ratios against the values for 0 h. The antibodies used in the ChIP assay were: CBP (sc369), p300 (sc585), KU70 (sc9033), KU80 (sc9034), BRM (610390), histone H3 (39164), gH2AX (05-636), acetylated H4 (K5/8/12/16) (06-866), acetylated H3 (K18) (07-354) and acetylated H3 (K56) (2134-1).
Laser micro-irradiation Laser micro-irradiation was performed using the FV-500 confocal scanning laser microscopy system (Olympus, Tokyo, Japan) as reported previously (Lan et al., 2005; Nakajima et al., 2006) . Briefly, cells in glass-bottomed dishes were microirradiated with a 405 nm pulse laser (Olympus). The laser was focused through a Â 40 objective lens. To examine endogenous CBP, p300, p53BP1 and gH2AX proteins, micro-irradiated H1299 cells were fixed and permeabilized with MeOH and acetone for 10 min at À20 1C, 10 min after micro-irradiation. The cells were subjected to an immunofluorescence assay using primary antibodies and secondary antibodies. Samples were stained with 90% glycerol/phosphate-buffered saline containing 1 mg/ml of paraphenylenediamine and 0.5 mg/ml of 4 0 ,6 0 -diamidino-2-phenylindole and observed using the FV-500 confocal scanning laser microscopy system. To examine yellow fluorescent protein-Cbp, GFP-KU70 or GFP-BRM localization, H1299 cells were transfected with the yellow fluorescent protein-Cbp (gifted from Dr Marc Tini), GFP-KU70 or GFP-BRM expression plasmids either with or without siRNA, 24 h before micro-irradiation. Fluorescence images were obtained after micro-irradiation. To quantitate protein accumulation at the laser-generated DSBs, the mean fluorescence intensity of the damaged regions within each cell was subtracted from that of the non-damaged nuclear regions. The values represent the mean ± s.d.
Comet assay
The neutral comet assay was performed using a Trevigen's Comet Assay kit (4250-050-K, Trevigen, Gaithersburg, MD, USA) according to the manufacturer's instructions. H1299 cells were exposed to 20 Gy of g-irradiation and subjected to comet analysis at the indicated time points. After staining with SYBR green, comet images were captured by fluorescence microscopy. Average Comet tail moment (percentage of DNA in tail Â tail length) was scored for three fields using the CometScore software (TriTek, Sumerduck,VA, USA). The values represent the mean ± s.d.
Abbreviations
DSB, DNA double-strand breaks; NHEJ, non-homologous end joining; HAT, histone acetyltransferase; ChIP, chromatin immunoprecipitation; IR, ionizing radiation.
